Cargando…

Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay

BACKGROUND: AMH levels determined by the conventional AMH assay declined during pregnancy and postpartum. A new Beckman Coulter AMH Gen II assay removes the potentially assay-interfering complement which is activated in pregnancy. The aim of this study was to evaluate if the decline of AMH levels in...

Descripción completa

Detalles Bibliográficos
Autores principales: Köninger, A., Schmidt, B., Mach, P., Damaske, D., Nießen, S., Kimmig, R., Strowitzki, T., Gellhaus, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528394/
https://www.ncbi.nlm.nih.gov/pubmed/26250904
http://dx.doi.org/10.1186/s12958-015-0082-4
_version_ 1782384679210450944
author Köninger, A.
Schmidt, B.
Mach, P.
Damaske, D.
Nießen, S.
Kimmig, R.
Strowitzki, T.
Gellhaus, A.
author_facet Köninger, A.
Schmidt, B.
Mach, P.
Damaske, D.
Nießen, S.
Kimmig, R.
Strowitzki, T.
Gellhaus, A.
author_sort Köninger, A.
collection PubMed
description BACKGROUND: AMH levels determined by the conventional AMH assay declined during pregnancy and postpartum. A new Beckman Coulter AMH Gen II assay removes the potentially assay-interfering complement which is activated in pregnancy. The aim of this study was to evaluate if the decline of AMH levels in the serum of pregnant women during the course of pregnancy and peripartum was assay-dependent and thus artificial. METHODS: In this cross-sectional study prepartal blood samples were collected from 62 patients (median age 30.6 years [interquartile range: 25.6 - 34.5]) in the third trimester of pregnancy and again 1–4 days after delivery between 2011 and 2012. In another cohort of 11 patients (median age 34.1 years [interquartile range: 32.6 - 37.8]) blood samples were taken in different trimesters of pregnancy between 1995 and 2001. The conventional and the modified AMH assay were performed in the same patient serum samples. We used the conventional and the modified AMH-Gen-II ELISA (Beckman Coulter, Immunotech, Webster, USA) for the assessment of AMH levels. The Wilcoxon signed rank test was used for determining differences between AMH levels pre- and postpartum. The method of Bland and Altman was applied for analyzing the agreement of both methods for determining AMH levels. RESULTS: AMH values peripartum were lower than those expected in fertile non-pregnant women of comparable age. An overall mean difference of 0.44 ng/ml was observed between the conventional and the modified assay. Measurements with the modified assay showed a significant decline of postpartal levels compared with prepartal levels which is consistent with values obtained using the conventional assay (both p < 0.00001). Compared to the longitudinal measurements of AMH levels determined using the conventional assay, AMH levels obtained using the modified assay suggest a steeper decline of values during the course of pregnancy. CONCLUSION: By comparing the conventional assay for AMH determination with the modified assay the present study confirmed that AMH levels decline during the course of pregnancy and early after delivery.
format Online
Article
Text
id pubmed-4528394
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45283942015-08-08 Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay Köninger, A. Schmidt, B. Mach, P. Damaske, D. Nießen, S. Kimmig, R. Strowitzki, T. Gellhaus, A. Reprod Biol Endocrinol Research BACKGROUND: AMH levels determined by the conventional AMH assay declined during pregnancy and postpartum. A new Beckman Coulter AMH Gen II assay removes the potentially assay-interfering complement which is activated in pregnancy. The aim of this study was to evaluate if the decline of AMH levels in the serum of pregnant women during the course of pregnancy and peripartum was assay-dependent and thus artificial. METHODS: In this cross-sectional study prepartal blood samples were collected from 62 patients (median age 30.6 years [interquartile range: 25.6 - 34.5]) in the third trimester of pregnancy and again 1–4 days after delivery between 2011 and 2012. In another cohort of 11 patients (median age 34.1 years [interquartile range: 32.6 - 37.8]) blood samples were taken in different trimesters of pregnancy between 1995 and 2001. The conventional and the modified AMH assay were performed in the same patient serum samples. We used the conventional and the modified AMH-Gen-II ELISA (Beckman Coulter, Immunotech, Webster, USA) for the assessment of AMH levels. The Wilcoxon signed rank test was used for determining differences between AMH levels pre- and postpartum. The method of Bland and Altman was applied for analyzing the agreement of both methods for determining AMH levels. RESULTS: AMH values peripartum were lower than those expected in fertile non-pregnant women of comparable age. An overall mean difference of 0.44 ng/ml was observed between the conventional and the modified assay. Measurements with the modified assay showed a significant decline of postpartal levels compared with prepartal levels which is consistent with values obtained using the conventional assay (both p < 0.00001). Compared to the longitudinal measurements of AMH levels determined using the conventional assay, AMH levels obtained using the modified assay suggest a steeper decline of values during the course of pregnancy. CONCLUSION: By comparing the conventional assay for AMH determination with the modified assay the present study confirmed that AMH levels decline during the course of pregnancy and early after delivery. BioMed Central 2015-08-07 /pmc/articles/PMC4528394/ /pubmed/26250904 http://dx.doi.org/10.1186/s12958-015-0082-4 Text en © Köninger et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Köninger, A.
Schmidt, B.
Mach, P.
Damaske, D.
Nießen, S.
Kimmig, R.
Strowitzki, T.
Gellhaus, A.
Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay
title Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay
title_full Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay
title_fullStr Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay
title_full_unstemmed Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay
title_short Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay
title_sort anti-mullerian-hormone during pregnancy and peripartum using the new beckman coulter amh gen ii assay
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528394/
https://www.ncbi.nlm.nih.gov/pubmed/26250904
http://dx.doi.org/10.1186/s12958-015-0082-4
work_keys_str_mv AT koningera antimullerianhormoneduringpregnancyandperipartumusingthenewbeckmancoulteramhgeniiassay
AT schmidtb antimullerianhormoneduringpregnancyandperipartumusingthenewbeckmancoulteramhgeniiassay
AT machp antimullerianhormoneduringpregnancyandperipartumusingthenewbeckmancoulteramhgeniiassay
AT damasked antimullerianhormoneduringpregnancyandperipartumusingthenewbeckmancoulteramhgeniiassay
AT nießens antimullerianhormoneduringpregnancyandperipartumusingthenewbeckmancoulteramhgeniiassay
AT kimmigr antimullerianhormoneduringpregnancyandperipartumusingthenewbeckmancoulteramhgeniiassay
AT strowitzkit antimullerianhormoneduringpregnancyandperipartumusingthenewbeckmancoulteramhgeniiassay
AT gellhausa antimullerianhormoneduringpregnancyandperipartumusingthenewbeckmancoulteramhgeniiassay